An Observational Study Evaluating the Safety of Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients Undergoing Surgery for Non‐Small Cell Lung Cancer
Neoadjuvant immunotherapy combined with chemotherapy was safe and effective and did not increase the difficulty of surgery for NSCLC; however, it was associated with a higher incidence of complications than neoadjuvant chemotherapy alone (p < 0.05).
Authors
- Jinbai Miao (ORCID: https://orcid.org/0000-0001-5027-813X)
- Xin Ye (ORCID: https://orcid.org/0000-0002-7406-0482)
- Hui Li (ORCID: https://orcid.org/0000-0003-0579-3858)
- Bin Hu (ORCID: https://orcid.org/0000-0001-5906-1527)
Institutions
- Capital Medical University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/1759-7714.70002
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52